Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Keystone

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
Rheumatology (Oxford, England)|June 22, 2012
Developing an effective treatment algorithm for rheumatoid arthritisEdward C Keystone, Josef Smolen, Piet van Riel
Joint Bone Spine|April 27, 2005
Asymmetry of small joint involvement in rheumatoid arthritis: prevalence and tendency towards symmetry over timePhilippe Zangger, Edward C Keystone, Earl R Bogoch
The Journal of Rheumatology. Supplement|May 4, 2010
From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory DiseasesBoulos Haraoui, Anthony S Russell, Edward C Keystone
The Journal of Rheumatology|September 4, 2012
Risk of failure of a clinical drug trial in patients with moderate to severe rheumatoid arthritisKavisha S Jayasundara, Edward C Keystone, Jayson L Parker
Arthritis and Rheumatism|April 29, 2006
Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled studyPhilip J Mease, Dafna D Gladman, Edward C Keystone, et al.
Journal of Autoimmunity|March 8, 2016
Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritisCarole L Galligan, Edward C Keystone, Eleanor N Fish
Cornea|December 19, 2008
Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-upSilvia Odorcic, Edward C Keystone, Joseph J K Ma
ACR Open Rheumatology|March 15, 2020
Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid ArthritisMohammad Movahedi, Deborah Weber, Pooneh Akhavan, et al.
Arthritis Research & Therapy|June 16, 2006
Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblastsAlison M Connor, Stuart Berger, Aru Narendran, et al.
Arthritis and Rheumatism|October 2, 2007
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patientsDaniel Aletaha, Julia Funovits, Edward C Keystone, et al.
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
Rheumatology (Oxford, England)|June 22, 2012
Developing an effective treatment algorithm for rheumatoid arthritisEdward C Keystone, Josef Smolen, Piet van Riel
Joint Bone Spine|April 27, 2005
Asymmetry of small joint involvement in rheumatoid arthritis: prevalence and tendency towards symmetry over timePhilippe Zangger, Edward C Keystone, Earl R Bogoch
The Journal of Rheumatology. Supplement|May 4, 2010
From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory DiseasesBoulos Haraoui, Anthony S Russell, Edward C Keystone
The Journal of Rheumatology|September 4, 2012
Risk of failure of a clinical drug trial in patients with moderate to severe rheumatoid arthritisKavisha S Jayasundara, Edward C Keystone, Jayson L Parker
Arthritis and Rheumatism|April 29, 2006
Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled studyPhilip J Mease, Dafna D Gladman, Edward C Keystone, et al.
Journal of Autoimmunity|March 8, 2016
Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritisCarole L Galligan, Edward C Keystone, Eleanor N Fish
Cornea|December 19, 2008
Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-upSilvia Odorcic, Edward C Keystone, Joseph J K Ma
ACR Open Rheumatology|March 15, 2020
Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid ArthritisMohammad Movahedi, Deborah Weber, Pooneh Akhavan, et al.
Arthritis Research & Therapy|June 16, 2006
Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblastsAlison M Connor, Stuart Berger, Aru Narendran, et al.
Arthritis and Rheumatism|October 2, 2007
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patientsDaniel Aletaha, Julia Funovits, Edward C Keystone, et al.
Pageof 16